In a buoyant economy like this, why do so many feel the grip of creeping gloom? In the 3rd quarter of 2018, the US GDP grew by 3%. Inflation scored a tame 1.6%. There are 7.3 million job openings available – more jobs available than there are unemployed people – 6.5 million in January 2019. […]
In fiscal year 2018, the USPS reported $3.9 billion in losses, up from the $2.7 bilion loss it experienced in 2017. It’s been over a decade since the USPS was last profitable, which is particularly concerning given that the agency was intended to be financially self-sufficient. Adding to its financial challenges, the USPS rarely meets […]
DNA sequencing (determining the precise order of nucleotides in a DNA molecule) for humans was first performed in 1977. The process was so time consuming and costly that DNA sequencing was performed only for important medical research. The first complete organism sequenced was an influenza bacterium in 1995. The Human Genome Project was not completed […]
For decades, scientists around the world have dreamed of medical interventions to repair or replace defective genes in a targeted way. Today, that vision is becoming reality for an ever-growing number of debilitating and deadly diseases thanks to breakthroughs in gene therapy technology. But if millions of Americans are to benefit from these advances, our […]
For those of us concerned that states’ occupational licensing laws are inhibiting economic opportunity and hurting consumers, 2019 is off to a good start. Occupational licensing laws, which make it illegal to work in an occupation without getting the government’s permission, have proliferated over the last few decades. Today, licensing affects as many as 3 […]
While we are well into the new year, but not much has changed at the U.S. Postal Service. The agency continues to hemorrhage cash, miss quality of service targets, and accrue massive unfunded liabilities. In fiscal year 2018, the USPS reported $3.9 billion in losses — the latest in a decade-long trend of deepening operating […]
Biopharmaceuticals are preparations synthesized from living organisms, especially a human or animal protein, such as a hormone or antitoxin that is used as a diagnostic, preventive, or therapeutic agent. If the preparation is the original drug, it can be patented. Most of us have seen TV adverts for patented new wonder drugs such as Humira, […]
A major assault on consumer sovereignty is imminent, according to newly unveiled plans by the EAT-Lancet Commission, a billionaire-funded organization with deep ties to radical food activists, to impose a near-vegan diet on the world’s population through punitive taxation, rationing, and outright bans of disfavored products. A few weeks ago, EAT-Lancet released a report promoting […]
As the new legislative session begins, Congress should demand increased transparency, require flow-through of manufacturer rebates to lower consumer prices, prohibit clawbacks, and consider giving federal agencies expanded oversight responsibilities to monitor PBMs’ practices. This op-ed explains why.
Today, ACI joined a coalition of think tanks calling for approval of the T-Mobile/Sprint merger. The letter finds the transaction would increase competition, thereby producing consumer benefits. The letter is available online.